About Elan
Elan is a company based in Dublin (Ireland) founded in 1969 was acquired by Perrigo in July 2013. Elan has completed 5 acquisitions, including AOP Orphan Pharmaceuticals, Athena Neurosciences and Delsys Pharmaceutical Corporation. Elan offers products and services including Ibuprofen Tablets, Acetaminophen, Minoxidil Topical Solution, Nicotine Polacrilex Lozenge, and Allergy Relief Loratadine. Elan operates in a competitive market with competitors including Kapiva, ChromaDex, Labomar, LifeVantage and Mojocare, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Perrigo Company Plc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
AOP Orphan Pharmaceuticals
& 4 more
-
Acquired by
Perrigo
(Jul 29, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elan
Elan offers a comprehensive portfolio of products and services, including Ibuprofen Tablets, Acetaminophen, Minoxidil Topical Solution, Nicotine Polacrilex Lozenge, and Allergy Relief Loratadine.
Provides relief from pain and inflammation for consumers.
Treats fever and minor aches effectively.
Promotes hair growth for men as an over-the-counter treatment.
Aids in quitting smoking by reducing cravings.
Relieves allergy symptoms like itching and sneezing.
Funding Insights of Elan
Detailed funding history for Elan
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Elan
Elan has secured backing from 1 investor. Prominent investors backing the company include Perrigo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs, OTC pharmaceuticals, and nutritional products are manufactured and distributed.
|
Locked | Locked | Locked |
Investor details for Elan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elan
Elan has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include AOP Orphan Pharmaceuticals, Athena Neurosciences and Delsys Pharmaceutical Corporation.
Investment portfolio details for Elan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops, produces and distributes innovative drugs and administration methods for rare diseases
|
Locked | Locked | 1996 | Locked | |
|
Limited information available
|
Locked | Locked | 1995 | Locked | |
|
Biopharmaceutical therapies for neurological diseases and pain are developed.
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for Elan
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Elan
Detailed financials for Elan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elan Comparisons
Peer comparison for Elan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elan
Elan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, ChromaDex, Labomar, LifeVantage and Mojocare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| Locked | Locked | Locked |
Nutritional ingredients for health and wellness are developed.
|
|
| Locked | Locked | Locked |
Dietary supplements, diet foods, health products, and medical devices
|
|
| Locked | Locked | Locked |
Nutritional products for various health ailments are provided.
|
|
| Locked | Locked | Locked |
Personalized wellness solutions are delivered via a digital healthcare platform.
|
|
| Locked | Locked | Locked |
Nutritional supplements are provided to enhance health and wellness.
|
Detailed competitors of Elan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elan
Complete news archive for Elan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elan
Elan was founded in 1969.
Elan is headquartered in Dublin, Ireland.
Perrigo is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) products, prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri. Nutrition products include infant formula, paediatric nutrition and vitamins, minerals, and supplements. Perrigo has acquired Neurex Corporation, Delsys Pharmaceuticals and AOP Orphan Pharmaceuticals. The company has operations in more than 30 countries across North America, Europe, Asia, South America, and Australia. Perrigo API (formerly Chemagis), a division of Perrigo develops, produces, and markets APIs and FDFs for the branded and generic pharmaceutical industries. Perrigo API has FDA-inspected and cGMP compliant facilities in Israel, Germany and India.
Elan offers Ibuprofen Tablets, Acetaminophen, Minoxidil Topical Solution, Nicotine Polacrilex Lozenge, and Allergy Relief Loratadine.
Elan has made 5 acquisitions, including AOP Orphan Pharmaceuticals, Athena Neurosciences, and Delsys Pharmaceutical Corporation.
Elan has 1 investor. Key investors include Perrigo.